Stockscreener 앱 받기
97.66
0.65%
0.63
전일 마감가:
$97.03
열려 있는:
$96.69
하루 거래량:
8.26M
Relative Volume:
1.11
시가총액:
$125.20B
수익:
$35.48B
순이익/손실:
$4.64B
주가수익비율:
27.26
EPS:
3.582
순현금흐름:
$5.41B
1주 성능:
+0.83%
1개월 성능:
-3.01%
6개월 성능:
+6.09%
1년 성능:
+7.63%
1일 변동 폭
$96.30
$98.06
1주일 범위
$95.89
$98.98
52주 변동 폭
$79.55
$106.33
메드트로닉 Stock (MDT) Company Profile
명칭
Medtronic Plc
전화
01135314381700
주소
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
97.66 | 124.39B | 35.48B | 4.64B | 5.41B | 3.582 |
|
ABT
Abbott Laboratories
|
116.35 | 202.16B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
387.46 | 147.74B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
BSX
Boston Scientific Corp
|
76.85 | 112.40B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
86.47 | 49.85B | 6.07B | 1.06B | 799.60M | 1.8527 |
메드트로닉 Stock (MDT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-13 | 재개 | Barclays | Overweight |
| 2026-02-09 | 업그레이드 | Needham | Hold → Buy |
| 2026-02-03 | 재개 | Citigroup | Buy |
| 2026-01-30 | 재개 | Wells Fargo | Overweight |
| 2026-01-06 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2025-11-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2025-06-30 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-10-10 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | 재확인 | Oppenheimer | Perform |
| 2024-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2024-08-14 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Sell |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | 다운그레이드 | UBS | Buy → Sell |
| 2023-01-09 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-11-23 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-11-16 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-08-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-06-01 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-12-16 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-06-10 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-12-15 | 업그레이드 | Goldman | Sell → Neutral |
| 2020-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | 업그레이드 | Stifel | Hold → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-05-14 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2020-03-30 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2020-03-25 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Sell |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-02 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-06-05 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | 재확인 | Needham | Strong Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-12-19 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-08-27 | 재확인 | Argus | Buy |
모두보기
메드트로닉 주식(MDT)의 최신 뉴스
Global Medical Device Cleaning Market Poised for Strong Growth as Infection Control Mandates and Reprocessing Technologies Accelerate Adoption: Verified Market Research® - GlobeNewswire Inc.
US Bancorp DE Trims Stake in Medtronic PLC $MDT - MarketBeat
Westfield Capital Management Co. LP Sells 11,893 Shares of Medtronic PLC $MDT - MarketBeat
Daiwa Securities Adjusts Price Target on Medtronic to $115 From $117, Maintains Buy Rating - marketscreener.com
Andra AP fonden Has $30.58 Million Stock Position in Medtronic PLC $MDT - MarketBeat
Medtronic PLC (NYSE:MDT) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Medtronic (NYSE:MDT) EVP Sells $5,132,120.04 in Stock - MarketBeat
Medtronic Data Backs Altaviva Tibial Neuromod for Urinary Incontinence - Medical Product Outsourcing
On the Radar: Medtronic - Barron's
Westpac Banking Corp Purchases 34,673 Shares of Medtronic PLC $MDT - MarketBeat
Is Medtronic Stock Underperforming the S&P 500? - Barchart.com
Mitsubishi UFJ Asset Management Co. Ltd. Boosts Stake in Medtronic PLC $MDT - MarketBeat
K.J. Harrison & Partners Inc Makes New $1.59 Million Investment in Medtronic PLC $MDT - MarketBeat
TD Asset Management Inc Cuts Position in Medtronic PLC $MDT - MarketBeat
Medtronic begins EMEA commercial launch of MiniMed Go Smart MDI system with Simplera sensor - BioSpace
Medtronic (MDT) Launches MiniMed Go Smart MDI System in Europe - GuruFocus
1,326,614 Shares in Medtronic PLC $MDT Acquired by Magellan Asset Management Ltd - MarketBeat
Medtronic’s diabetes business MiniMed looks for $784m in US IPO - Medical Device Network
Medtronic’s MiniMed prices IPO at up to $784M - MedTech Dive
How Investors Are Reacting To Medtronic (MDT) Balancing Growth, Margin Pressure, And A Diabetes Spin-Off - simplywall.st
MiniMed IPO Seeks $784M, Valuing Medtronic Spin-Off at $7.86B - Medical Device and Diagnostic industry
Medtronic's Diabetes Spinoff MiniMed Seeks $742M IPO - Law360
Medtronic diabetes unit MiniMed seeks $784 million in US IPO - Yahoo Finance
Medtronic’s diabetes unit Minimed seeks $784M in IPO - BioWorld MedTech
Medtronic (MDT) Subsidiary MiniMed Group Initiates IPO Roadshow - GuruFocus
Medtronic MiniMed Diabetes unit prices IPO at up to $784M - MassDevice
The Great Unlocking: Medtronic’s Strategic Pivot and the MiniMed Spin-Off - FinancialContent
Medtronic Unit MiniMed Launches IPO Roadshow - marketscreener.com
Medtronic diabetes unit MiniMed seeks $784 million in IPO By Investing.com - Investing.com Nigeria
MiniMed Launches IPO Roadshow - marketscreener.com
Medtronic Plc Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
MiniMed announces launch of IPO roadshow - PR Newswire
Medtronic Diabetes Business MiniMed Seeks $784 Million in US IPO - Bloomberg
Miller Investment Management LP Sells 10,280 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic’s diabetes unit MiniMed seeks up to $784M in U.S. IPO - Seeking Alpha
Nkcfo LLC Invests $8.04 Million in Medtronic PLC $MDT - MarketBeat
First Financial Bankshares Inc Buys 13,399 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic's MiniMed targets $7.9 billion valuation in US IPO - marketscreener.com
Medtronic's MiniMed aims to raise $784 million in US IPO - AOL.com
Medtronic's diabetes unit MiniMed eyes $7.9 billion valuation in US IPO - Reuters
Dakota Wealth Management Has $14.93 Million Stock Position in Medtronic PLC $MDT - MarketBeat
Medtronic plc (MDT) Gains Momentum Through Diabetes and Cardiovascular Operations - Insider Monkey
Clark Estates Inc. NY Has $21.43 Million Position in Medtronic PLC $MDT - MarketBeat
Medtronic: A Healthcare Giant with 48 Years of Dividend Increases - Intellectia AI
1 Reason I'd Buy Medtronic Stock and Never Sell - The Motley Fool
Dividend Medtech Giant Medtronic Is Built to Survive Any Market Crash - The Motley Fool
EDENTREE ASSET MANAGEMENT Ltd Raises Position in Medtronic PLC $MDT - MarketBeat
Bleakley Financial Group LLC Purchases 13,177 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic (NYSE:MDT) Price Target Cut to $103.00 by Analysts at Truist Financial - MarketBeat
Medtronic: The Investment Appeal of a Medical Device Giant - Intellectia AI
Medtronic (NYSE:MDT) Upgraded at Mizuho - Defense World
메드트로닉 (MDT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
자본화:
|
볼륨(24시간):